Cargando…

Simulation of Pool Testing to Identify Patients With Coronavirus Disease 2019 Under Conditions of Limited Test Availability

This decision analytical model study examines the feasibility of using pool testing to identify patients with coronavirus disease 2019 (COVID-19) in a setting with limited testing availability.

Detalles Bibliográficos
Autores principales:	Cherif, Alhaji, Grobe, Nadja, Wang, Xiaoling, Kotanko, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315509/ https://www.ncbi.nlm.nih.gov/pubmed/32573706 http://dx.doi.org/10.1001/jamanetworkopen.2020.13075

Ejemplares similares

Sample pooling: burden or solution?
por: Grobe, Nadja, et al.
Publicado: (2021)

Testing of worn face mask and saliva for SARS-CoV-2
por: Wang, Xiaoling, et al.
Publicado: (2023)

Pooling of coronavirus tests under unknown prevalence
por: Pikovski, A., et al.
Publicado: (2020)

Statistical tests and identifiability conditions for pooling and analyzing multisite datasets
por: Zhou, Hao Henry, et al.
Publicado: (2018)

The Piezo1 hypothesis of renal anemia
por: Kotanko, Peter, et al.
Publicado: (2022)

SARS-CoV-2 Seropositivity Rates in Patients and Clinical Staff in New York City Dialysis Facilities: Association With the General Population
por: Thwin, Ohnmar, et al.
Publicado: (2021)

A mathematical model of parathyroid gland biology
por: Schappacher‐Tilp, Gudrun, et al.
Publicado: (2019)

SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients
por: Wang, Xiaoling, et al.
Publicado: (2022)

Microbiological Testing for Coronavirus Disease 2019
por: Yamamoto, Kei, et al.
Publicado: (2021)

Test, test, test – a complication of testing for coronavirus disease 2019 with nasal swabs
por: Mughal, Z, et al.
Publicado: (2020)

Cost analysis of coronavirus disease 2019 test strategies using pooled reverse transcriptase‐polymerase chain reaction technique
por: Kim, Eun Young, et al.
Publicado: (2022)

Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability—Does One Exist?
por: Virmani, Sarthak, et al.
Publicado: (2020)

Optimal size of Sample Pooling for RNA Pool Testing: An Avant-Garde for Scaling up Severe Acute Respiratory Syndrome Coronavirus-2 Testing
por: Khodare, Arvind, et al.
Publicado: (2020)

Coronavirus disease 2019 antibody testing in pregnancy
por: Zullo, Fabrizio, et al.
Publicado: (2020)

A theoretical simulation of SARS-CoV-2 pooled testing: Pooled sample collection outperforms pooled RNA extraction
por: He, Yugan, et al.
Publicado: (2021)

Identification of arterial oxygen intermittency in oximetry data
por: Galuzio, Paulo P., et al.
Publicado: (2022)

Simulation of pooled-sample analysis strategies for COVID-19 mass testing
por: Deckert, Andreas, et al.
Publicado: (2020)

Linking of Rasch-Scaled Tests: Consequences of Limited Item Pools and Model Misfit
por: Fischer, Luise, et al.
Publicado: (2021)

Pooled testing efficiency increases with test frequency
por: Augenblick, Ned, et al.
Publicado: (2022)

Testing a candidate meiotic drive locus identified by pool sequencing
por: Barbash, Daniel A, et al.
Publicado: (2023)

The importance of Coronavirus Disease 2019 testing in cardiac surgery
por: Maj, Giulia, et al.
Publicado: (2020)

The Importance of Universal Preprocedural Testing for the Novel Coronavirus 2019
por: Zhang, Felicia, et al.
Publicado: (2020)

Rapid testing for coronavirus disease 2019 (COVID-19)
por: Biby, Alexander, et al.
Publicado: (2022)

Pool Size Selection When Testing for Severe Acute Respiratory Syndrome Coronavirus 2
por: Bilder, Christopher R, et al.
Publicado: (2020)

Patent pools and diagnostic testing
por: Verbeure, Birgit, et al.
Publicado: (2006)

Optimally pooled viral testing
por: Ben-Amotz, Dor
Publicado: (2020)

Healthcare workers’ perspectives on coronavirus testing availability: a cross sectional survey
por: Byhoff, Elena, et al.
Publicado: (2021)

Pooled testing of traced contacts under superspreading dynamics
por: Tsirtsis, Stratis, et al.
Publicado: (2022)

Using discrete event simulation to optimize nucleic acid testing process for coronavirus disease 2019 (COVID-19)
por: Guan, Wenda, et al.
Publicado: (2022)

Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020)

Antibody testing for coronavirus disease 2019: not ready for prime time
por: Duong, Yen T, et al.
Publicado: (2020)

Assessing the Value of Diagnostic Tests in the Coronavirus Disease 2019 Pandemic
por: Sardanelli, Francesco, et al.
Publicado: (2020)

Ideal Test Time for Coronavirus Disease 2019 Contact Tracing
por: Miyake, Shigeta, et al.
Publicado: (2022)

Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types
por: Jörg, David J, et al.
Publicado: (2022)

Constructions and Comparisons of Pooling Matrices for Pooled Testing of COVID-19
Publicado: (2021)

Boosting test-efficiency by pooled testing for SARS-CoV-2—Formula for optimal pool size
por: Hanel, Rudolf, et al.
Publicado: (2020)

Feasibility, efficiency & effectiveness of pooled sample testing strategy (pooled NAAT) for molecular testing of COVID-19
por: Prakash, Shantanu, et al.
Publicado: (2021)

SAFEE: A Debriefing Tool to Identify Latent Conditions in Simulation-based Hospital Design Testing
por: Colman, Nora, et al.
Publicado: (2020)

Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season
por: Sakai-Tagawa, Yuko, et al.
Publicado: (2019)

The limitations, dangers, and benefits of simple methods for testing identifiability
por: Castro, Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_52ucfhftg612fo1mk77ckhlp0r